Co-targeting PIM kinase in drug resistant Non-Small Cell Lung Cancer (Q233284): Difference between revisions
Jump to navigation
Jump to search
(Created claim: fund (P1584): European Regional Development Fund (Q2504369), Adding fund) |
(Removed claim: EU contribution (P835): 16,929.635 euro) |
||||||
| Property / EU contribution | |||||||
| |||||||
| Property / EU contribution: 16,929.635 Euro / rank | |||||||
Revision as of 06:58, 25 September 2020
Project in Ireland financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Co-targeting PIM kinase in drug resistant Non-Small Cell Lung Cancer |
Project in Ireland financed by DG Regio |
Statements
33,859.27 Euro
0 references
50.0 percent
0 references
1 January 2016
0 references
1 January 2018
0 references
Trinity College Dublin
0 references
Co-targeting PIM kinase in drug resistant Non-Small Cell Lung Cancer (English)
0 references
Identifiers
215
0 references